In nine types of cancer, the expression level of at least one CXCR2 ligand positively correlated with tumor infiltration by plasmacytoid DCs, while none of the CXCR2 ligands negatively correlated with the count of DCs. The gene discussed is CXCR2; the disease is neoplasm.